Assessing the impact of TB/HIV services integration on TB treatment outcomes and their relevance in TB/HIV monitoring in Ghana by Ansa, GA et al.
Ansa et al. Infectious Diseases of poverty 2012, 1:13
http://www.idpjournal.com/content/1/1/13RESEARCH ARTICLE Open AccessAssessing the impact of TB/HIV services
integration on TB treatment outcomes and their
relevance in TB/HIV monitoring in Ghana
Gloria Akosua Ansa1*, John D Walley2, Kamran Siddiqi3 and Xiaolin Wei4Abstract
Background: The impact of the human immunodeficiency virus (HIV) on tuberculosis (TB), and the implications for
TB and HIV control, is a public health challenge in Ghana – almost a quarter (23%) of all TB cases were HIV positive in
2010. The integration of TB/HIV services has therefore emerged as an essential component of the national response
to TB and HIV. The aim is to reduce fragmentation, improve access, enhance efficiency and improve quality of care.
Ghana’s TB/HIV policy comprises three linked sets of activities: effective implementation of the Stop TB Strategy for TB
control, improved HIV prevention and care, and the implementation of additional TB/HIV activities. Different models of
service delivery with increasing integration of TB/HIV activities are expected to provide greater access to more
comprehensive care. The objective of this paper is to assess the impact of TB/HIV integration on TB treatment
outcomes and to explore the usefulness of TB treatment outcomes as TB/HIV indicators.
Methods: A before-and-after study to observe the introduction of TB/HIV activities into TB programmes in three
hospitals with different levels of integration was conducted. Anonymised patient data was collated from TB registers
from each facility, and analysed to determine if TB treatment outcomes changed significantly after integration.
Results: TB treatment success was 50% (95% CI 49 – 52) prior to, and 69% (95% CI 65 – 73) after, integration
(Χ2 43.96, p < 0.00). Treatment success increased from 43% to 53% at the one-stop shop (OSS), from 69% to 78% at
the partially integrated site (PIS) and substantially from 46% to 78% at the referral site (RS) (Χ2 64.54; p<0.01). Defaults
and cases transferred out reduced from 14.3% and 15.3% prior to integration, to 1.4% and 9.0% after integration,
respectively, accounting for a significant increase in treatment success. Death rates remained high at 18% in all cases
studied and 25% in HIV-associated cases after integration.
Conclusion: TB/HIV integration may improve TB treatment success, but its exact impact is difficult to ascertain due to
non-specificity and design limitations. TB mortality may be more useful as an indicator for monitoring TB/HIV activities
in Ghana.
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Background
Introduction
The impact of HIV on TB, and the implications for TB
and HIV control, has been acknowledged as a public
health challenge in Ghana, as is the case in many other
Sub-Saharan African countries. Almost a quarter (23%)
of all TB cases in Ghana were HIV positive in 2010 [1],
up from 12% the previous year [2]. The WHO TB/HIV
policy pursues the following objectives:
 To establish and strengthen the mechanisms of
collaboration and joint management between HIV
programmes and TB-control programmes for
delivering integrated TB and HIV services,
preferably at the same time and location;
 To reduce the burden of TB in people living with
HIV and in their families and communities, and to
initiate antiretroviral therapy (ART) early and in line
with WHO guidelines; and
 To reduce the burden of HIV in patients with
presumptive and diagnosed TB, and in their families
and communities, by providing HIV prevention,
diagnosis and treatment [3].
TB treatment in Ghana dates back to the pre-
independence era but the National TB Control
Programme (NTP) was established in 1994 and the
WHO-approved Directly Observed Treatment Short
course (DOTS) strategy was then also adopted. TB con-
trol in Ghana is highly decentralised with services avail-
able in most health facilities and in some communities.
National prevalence is estimated at 201 per 100,000
population [1]. The National AIDS and STIs Control
Programme (NACP) was established in 1987, and ART
was introduced on a pilot basis in 2003. HIV care and
ART started with a very centralised approach, but have
since been progressively decentralised from the teaching
hospitals down to the district hospitals. Until 2007, TB
and HIV services were mostly segregated and referral
services were the only form of integration.
TB and HIV services were disconnected, which meant
an increase in the cost of care for patients, as well as
other added inconveniences, as numerous visits were
required to access the required care. There were higher
losses to follow-up and case fatalities, as well as delays
in ART initiation. Although TB programme indicators
like case notification, default rates and case evaluation
had been progressively improving under the existing TB
control interventions, death rates were high andtreatment success remained below the global target of
85% [2]. In 2005, a national TB/HIV technical commit-
tee was set up to develop a TB/HIV policy and to define
treatment guidelines, which were completed in 2007. In
June 2007, TB/HIV activities were incorporated into the
existing TB and HIV services.
The integration of TB and HIV services provides a uni-
fied strategy to address the burden of TB/HIV [4]. The
aim of integrated health services is to organise and man-
age the services so that people can get the health care they
need [5]. In TB and HIV control, integration of services
has emerged as an essential component in any country’s
response to the TB/HIV dual epidemic – the aim being to
create coherence and synergy between the two pro-
grammes, not only to address problems with access and
fragmentation, but also to enhance efficiency, quality of
care and consumer satisfaction [6]. In line with this, the
strategic framework of Ghana’s TB/HIV policy consists of
three linked sets of activities: effective implementation of
the Stop TB Strategy for TB control, improved HIV pre-
vention and care, and the implementation of a set of add-
itional collaborative TB/HIV activities [7].
Conceptual framework
Different models of service delivery for TB/HIV activities
have been described [3,8] based on integration being a
continuum from segregation (through linkage and col-
laboration) to full integration, according to the degree of
integration [9-11]. In addition, increasing integration is
expected to be associated with greater access to more
comprehensive care (Figure 1).
This figure illustrates the continuum of integration
from completely separated service units to full integra-
tion, where collaborating units combine to form a single
unit. This model forms the basis for the service delivery
models for TB/HIV services.
This improved access to comprehensive care is antici-
pated to improve the outcomes of both TB and HIV care
[5,12]. Although three models have been previously
described [4,7,8], the current WHO TB/HIV policy [3]
expands on these to create a five-tier model (Table 1).
TB treatment outcomes measured by the TB pro-
gramme in Ghana include the following cases: cured,
completed treatment, died, defaulted, failed or transferred
out. The cases which are ‘cured’ or ‘completed treatment’
together constitute successful TB treatment outcomes,
while the rest represent adverse or unsuccessful outcomes.
TB treatment success is a measure of a TB programme’s
capacity to retain patients throughout a complete course
of treatment. It has a direct impact on mortality and is
also influenced by other TB control processes [13]. In TB/
HIV care, outcomes are useful for studying the perform-
ance of healthcare provision and for detecting problems in
its implementation [13].
Full 
integration
CollaborationLinkageFull 
segregation
Figure 1 Continuum of integration of health services forming the basis of TB/HIV service delivery models.
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The national approach to the implementation of the TB/
HIV policy has been gradual and incremental so that
evidence of effective implementation can be used to in-
form nationwide scale-up. This paper is therefore part of
a study that was intended to generate recommendations
to inform TB/HIV integration. The specific objective of
this paper is to assess the impact of TB/HIV integration
on TB treatment outcomes and to explore the relevance
of TB treatment outcomes as indicators of TB/HIV inte-
gration in Ghana. Findings from the comparisons of the
effectiveness of the three different models will be reported
in another paper.
Methods
This study was conducted in the Eastern region of Ghana
in three district hospitals, representing increasing levels of
integration, namely referral site (RS), partially integrated
site (PIS) and one-stop shop (OSS), which corresponded
to linkages, collaboration and full integration, respectively
(Figure 1, Tables 1 & 2). The Eastern region consistently
has one of the highest HIV prevalence in Ghana. At the
time of the study, HIV prevalence was 4.2% in the region,
with the highest rate being 5.8% in cities where the PIS
and the RS were located. All three hospitals were located
in urban areas and served as referral centres for health
centres, community clinics and other private health facil-
ities within the districts. The three main economic activ-
ities in the districts are agriculture, trading and the service
industry.
A before-and-after study involving all TB patients
registered between January 2006 and December 2008
was done at each of the sites. This was part of a PhD
study data collection period. Data collection ended in
September 2009 when all TB patients had completed
their six- or eight-month treatment programmes.
This study was a sort of ‘natural experiment’ to observe
introduction of collaborative TB/HIV activities into exist-
ing TB control activities for the first time and thisTable 1 Relationship between the level of integration and dif
Level of integration Study delivery models WHO
Linkage Referral Entry
Entry
Collaboration Partially integrated Entry
Entry
Full Integration One-stop shop TB ahappened in June 2007. Hence, January 2006 to May
2007 can be classified as ‘before integration’ and June
2007 to December 2008 as ‘after integration’. The TB/
HIV intervention included providing recommended drug
therapy for all registered TB cases, provider-initiated
counselling and testing (PICT) of all registered TB cases
for HIV, initiation of co-trimoxazole preventive therapy
(CPT) to reduce other infections, and antiretroviral ther-
apy (ART) for all eligible HIV-positive TB cases. There
was also the introduction of a modified TB register that
records TB/HIV activities.
Anonymised and aggregated patient data from TB reg-
isters of each facility were used to compute outcomes.
The data was checked for accuracy, followed by descrip-
tive and statistical analysis using Windows Excel and
Statistical Product and Service Solutions (SPSS). ‘Cured’
and ‘completed’ outcomes were re-classified as ‘success-
ful’, while the rest (died, defaulted, transferred and fail-
ure) were re-classified as ‘unsuccessful’. Missing data
were not included in the determination of outcomes.
Chi-square (X2) statistical tests were used to examine
whether or not there was any association between TB/
HIV integration and TB treatment outcomes. And prob-
ability (p) -values and confidence intervals were also
employed to determine how significant differences in TB
treatment outcomes before and after integration were.
Ethical approval was obtained from the University of
Leeds and the Ghana Health Service.
Results
There were 1330 TB cases registered from January 2006
to December 2008: 727 (55%) were registered before in-
tegration and 603 (45%) were registered after. About
96% (1275) of these were evaluated at the end of treat-
ment (Table 3).
A total of 708 (97%) cases registered before integration
were evaluated at the end of TB treatment: 50% were
successful, 19% died, 14% defaulted and 15% were trans-
ferred out after treatment had been initiated. Afterferent service delivery models
descriptions
via TB service and referral for HIV testing and care.
via HIV service and referral for screening, diagnosis and treatment of TB.
via TB service and referral for HIV care after HIV testing.
via HIV service and referral after TB screening.
nd HIV services provided at a single facility.
Table 2 TB/HIV intervention delivery at TB treatment centres at study sites
Characteristic One-stop shop Partial integration Referral
HIV pre-test counselling Available Available Available
HIV testing Available Referral to HIV unit Referral to HIV unit
CPT initiation and/or continuation Available Available Referral to HIV unit
ART initiation and/or continuation Available Referral to HIV unit Referral to HIV unit
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treatment: 69% were successful, 1% defaulted and cases
transferred out reduced to 9%. Deaths remained high at
18% after integration (Table 4).
Successful treatment outcomes seem to have increased
significantly from 50% (95% CI 49–52) before, to 69%
(95% CI 65–73) after integration (Χ2 43.96, p < 0.00).
There was no significant increase in treatment success
after integration at the OSS (Χ2 3.85, p<0.05) and PIS
(Χ2 1.56, p<0.26), but there appears to be a statistically
significant increase after integration at the RS (Χ2 64.54,
p<0.00). Over the period of study, successful outcomes
were lowest at the OSS (Figure 2). Although the PIS had
highly successful results after integration, the change
seemed significant only at the RS (Table 4).Table 3 Demographic characteristics of evaluated cases (exclu
Frequency (%)
Before (%) After (%)
N = 708 N = 567
Gender
Female 38.3 39.8
Male 61.7 60.2
Age
Mean (SD) 40.5 (18.0) 41.8 (18.4)
Median (IQR) 40 (22) 39 (24)
Range 1 - 97 2 - 105
Site of Disease
Pulmonary 92.7 88.5
Extra-pulmonary 7.3 11.5
Sputum at month 0
Positive 49.3 51.7
Negative 32.2 47.0
Not recorded 18.5 1.3
Patient Type
New 88.3 90.5
Defaulter 4.7 1.4
Failure 0.6 3.5
Relapse 5.6 4.1
Transferred in 0.7 0.5
Legend: SD - Standard deviation, IQR - Interquartile range.This figure depicts the trend of quarterly successful
TB treatment outcomes at the three study sites over the
three-year period of study.
The results indicate that, in general, there may be a
significant improvement in treatment success rates after
integration and TB cases were most likely to have a suc-
cessful outcome at the RS after integration.
Death rates reduced marginally from 18.8% (95% CI
18.5 - 19.0) before integration to 17.5% (95% CI 17.2 -
17.7) after, but this was not statistically significant. All
three sites had high death rates with no notable reduc-
tions after integration, except at the PIS where the death
rate increased from 15% to 22% (Table 4).
With cases transferred out during treatment, there
was a marked difference between the OSS and the otherding cases for which outcomes were not declared)
RS PIS OSS
N = 616 N = 284 N = 375
33.4 50.4 39.7
66.6 49.6 60.3
41.8 (18.5) 38.0 (17.5) 42.2 (18.0)
41 (25) 37 (20) 40 (24)
1 - 97 1 - 86 1 - 105
88.3 90.1 95.9
11.7 9.9 4.5
51.3 42.9 53.7
31.4 46.4 44.6
17.3 10.7 1.7
86.0 89.2 94.7
4.4 4.7 0.3
2.8 0.0 1.9
5.7 5.8 2.9
1.0 0.4 0.3
Table 4 TB treatment outcomes before and after integration at the study sites
Frequency (%)
All sites RS PIS OSS
Before (%) After (%) Before (%) After (%) Before (%) After (%) Before (%) After (%)
Cured 17.8 27.0 18.7 28.7 22.1 30.6 11.9 22.6
Completed 32.6 42.0 27.1 49.8 47.2 45.4 30.7 30.2
Defaulted 14.3 1.4 22.8 0.8 0.0 0.0 9.7 3.0
Died 18.8 17.5 18.7 15.0 15.3 21.5 22.2 18.1
Failure 1.3 2.3 1.6 4.0 0.6 0.8 1.1 1.0
Transferred out 15.3 9.0 11.1 0.8 14.7 0.8 24.4 24.1
Successful 50.4 69.0 45.8 78.5 69.3 76.0 42.6 52.8
95 % CI 48.8–52.4 64.9–72.9 43.9–48.2 70.8–86.2 61.9–76.7 65.7–86.3 39.9–45.3 48.9-56.6
Legend: CI - confidence interval.
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with peaks in 2006 and 2007 (Figure 3), and no signifi-
cant difference after integration (Table 4). The other two
sites had lower transfer rates and demonstrated a further
reduction after integration (Figure 3, Table 4).
This is a figure of the trend of the quarterly percen-
tages of TB patients transferred out at each of the three
study sites over the period of study. Cases transferred
out represent one of the key adverse outcomes of TB
treatment.
Defaulter rates fell significantly from 14.3% (95% CI
14.1 - 14.4) to 1% after integration (Χ2 66.55, p < 0.00).
At the individual sites, defaults reduced most signifi-
cantly at the RS, but were more unstable at the OSS.
There was, however, no record of default at the PIS,Legend:
RS – Referral site 
PIS – Partially integrated site 
OSS – One-stop shop 
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Figure 2 Trend of successful TB treatment outcomes at the three studwhich suggests problems with recording or signals an
inaccurate classification of cases.
Treatment success was 72% (95% CI 66–78) in HIV-
negative TB cases, as compared to 64% (95% CI 59–69)
in HIV-positive cases, while mortality in HIV-positive
cases was 25% (95% CI 24–26), as compared with 9.8%
(95% CI 9.7 - 10.0) among negative cases. Among HIV-
positive TB cases, treatment success was 75% for those
who were receiving ART and 61% for those who were
not. Mortality was 23% for those who were receiving
ART and 26% for those who were not.
Discussion
The results of this study suggest that, after integration,
successful TB treatment outcomes may have increased,Oct Jan Apr Jul Oct
2008
rters
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y sites over the study period.
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Figure 3 Trend of TB cases transferred out during treatment at study sites over the study period.
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increase that was observed only at the RS. The increase
was also lower than national levels due to factors such
as high mortality, particularly among HIV-positive
patients [14,15]. TB/HIV integration is primarily about
changing the processes of care and multidisciplinary
collaboration [16], and it is anticipated to increase pa-
tient-centeredness, enhance coordination and improve
continuity [6]. TB treatment outcomes would subse-
quently improve through better access, better resource
utilisation and enhanced efficiency [6,17]. However,
other concurrent TB or HIV, specific interventions may
lead to improved outcomes as well. Therefore, when
TB/HIV integration is introduced as part of a national
programme-improvement approach, successful TB treat-
ment outcomes are then a representation of the impact
of all the interventions. The specific impact of each indi-
vidual intervention becomes difficult to assess. This
underscores their non-specificity [18] as TB/HIV indica-
tors. In this study, for example, improvement in TB
treatment success was mainly due to decreases in
‘default’ and ‘transferred out’ cases, which may have only
improved as a result of other TB-specific control inter-
ventions that were in place, such as community-based
TB treatment and the use of treatment supporters in all
three study sites [19,20]. Consequently, although integra-
tion has the potential to improve TB treatment out-
comes, the extent of its contribution may be challenging
to assess due to the impact of concurrent strategies.
Among the adverse treatment outcomes, death rates
were high at all sites and reduced only marginally after
integration. Even though TB deaths include deaths from
any cause whilst undertaking TB treatment, research has
established that HIV-associated TB is related to anincreased risk of TB deaths [21]. Elliot et al. [22] demon-
strated that most deaths in cases of HIV-associated TB
result from active TB and its complications, or compli-
cations of the HIV infection itself. TB case fatality rates
in Africa are 16-35% in HIV-positive patients not receiv-
ing ART and 4-9% in HIV-negative patients [15]. The
study concurs with the study undertaken for this re-
search paper as mortalities in HIV-positive TB patients
were 25%, accounting for 59% of all TB deaths, as com-
pared to 10% among HIV-negative cases, accounting for
25% of all deaths. Even though the treatment success of
75% among HIV-positive TB cases receiving ART after
integration was comparable to the 72% as was demon-
strated by Huerga et al. [23], death rates were much
higher at 23% in HIV-associated cases, as opposed to the
10% in HIV-negative cases.
Based on the high death rates in the HIV-associated
TB cases with little or no apparent influence by other
TB-control processes, this study therefore suggests that
TB/HIV integration may have a more direct impact on
TB deaths than on successful treatment outcomes.
While HIV-associated TB accounted for 59% of all TB
deaths, the other concurrent TB-control interventions
seem to have had much less impact on mortality in Ghana
as compared to their impact on defaults and transfers out,
which significantly contributed to improved TB treatment
success. TB deaths may thus be a more sensitive indicator
for TB/HIV integration i.e. TB deaths among TB patients,
including those with HIV as well, may provide useful
information on the impact of TB/HIV integration.
It is recommended that TB deaths be further explored
as an indicator to monitor the impact of TB/HIV inte-
gration in similar contexts. This is with reference to the
propositions of Maher et al. [24] that TB deaths are
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limited by incomplete coverage of all incident TB cases,
inaccurate routine programme reporting of deaths, and
the unknown contribution of deaths from TB and HIV
alone. Even though Maher et al’s study focused on coun-
tries with high HIV prevalence in addition to heavy TB
burden, this study also suggests that TB mortalities can
be useful for monitoring TB/HIV integration in low-
income countries with relatively higher TB burden but
lower HIV prevalence. More research into the causes of
death among HIV-positive TB patients is therefore
required to identify and understand the causes of death
in order to properly assess its real usefulness as a TB/
HIV indicator.
Lack of randomisation and controls limit the internal
validity of this study as it subjects it to temporal and se-
lection bias. For that reason, the findings of this study
are presented not as categorical statements on the im-
pact of integration, but as a piloting of methods. More
rigorous studies are needed to assess the exact impact of
TB/HIV integration, and to improve TB/HIV monitoring
and evaluation. Another limitation is that evaluation was
mainly based on TB-related indicators due to the differ-
ent programme information systems, and the challenges
associated with access to HIV-patient data at the time of
the study.
Conclusions
In conclusion, this study suggests that although TB/HIV
integration has the potential to improve TB treatment
outcomes, assessing the exact contribution that TB/HIV
integration can have is challenging and requires more
rigorous evaluative studies. Due to the high TB death
rates among HIV-associated cases, TB mortality may be
a more useful indicator to use when researching the TB/
HIV burden in Ghana.
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